Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain.
Delgado Sillero I, Lopetegui Lia N, Sánchez Cousido LF, Rojas Piedra M, Távara Silva B, Garrido Onecha ML, Medina Valdivieso S, Alonso Horcajo N, Díez Tascón C, López González A, Castañón López C, Pedraza Lorenzo M, García Palomo A, Martín V, Diz Tain P. Delgado Sillero I, et al. Among authors: garcia palomo a. J Oncol Pharm Pract. 2023 Jun;29(4):854-860. doi: 10.1177/10781552221085253. Epub 2022 Mar 21. J Oncol Pharm Pract. 2023. PMID: 35306915
Experience with eribulin in HR+/HER2- metastatic breast cancer, including a male.
Mar Muñoz Sánchez MD, Carmen Soriano Rodríguez MD, Molina Garrido MJ, López-González A, García-Palomo A, López-González L, Plata Fernández MY, Caro NL, Rovira PS. Mar Muñoz Sánchez MD, et al. Future Oncol. 2018 Mar;14(7s):5-12. doi: 10.2217/fon-2017-0355. Future Oncol. 2018. PMID: 29611755
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors.
Méndez-Blanco C, Fondevila F, García-Palomo A, González-Gallego J, Mauriz JL. Méndez-Blanco C, et al. Among authors: garcia palomo a. Exp Mol Med. 2018 Oct 12;50(10):1-9. doi: 10.1038/s12276-018-0159-1. Exp Mol Med. 2018. PMID: 30315182 Free PMC article. Review.
Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.
Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, Amiano P, Fernandez-Villa T, Barricarte A, Tardon A, Diaz-Santos M, Peiro-Perez R, Marcos-Gragera R, Lope V, Gracia-Lavedan E, Alonso MH, Michelena-Echeveste MJ, Garcia-Palomo A, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J. Dierssen-Sotos T, et al. BMC Cancer. 2016 Aug 20;16(1):660. doi: 10.1186/s12885-016-2692-4. BMC Cancer. 2016. PMID: 27542890 Free PMC article.
Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy.
García-Girón C, García Palomo A, Alonso López C, León Carbonero A, Méndez Ureña M, Adróver Cebrián E, Barceló Galíndez R, Arroyo Yustos M, Alvarez Gallego J. García-Girón C, et al. Clin Transl Oncol. 2005 Jul;7(6):244-9. doi: 10.1007/BF02710170. Clin Transl Oncol. 2005. PMID: 16131447 Clinical Trial.
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
Bayo-Calero JL, Mayordomo JI, Sánchez-Rovira P, Pérez-Carrión R, Illaramendi JJ, García-Bueno JM, González-Flores E, Crespo C, Ramos-Vázquez M, García-Palomo A, Ruiz-Borrego M, de la Haba J, Gómez-Bernal A, Yubero-Esteban A. Bayo-Calero JL, et al. Clin Breast Cancer. 2008 Jun;8(3):264-8. doi: 10.3816/CBC.2008.n.030. Clin Breast Cancer. 2008. PMID: 18650157 Clinical Trial.
42 results